Proteomics

Dataset Information

0

DIA proteomics reveals the regulatory process of Sacubitril in the treatment of myocardial infarction reperfusion


ABSTRACT: As one of the major cardiovascular diseases, myocardial infarction is the most serious manifestation of coronary artery disease, which has attracted wide attention due to its high morbidity and mortality. The left anterior descending artery(LAD) of 6-8 weeks old male KM mice was ligated for 40min, followed by perfusion to establish an ischemia-reperfusion(I/R) model. After 3 days of monitoring, 60 mg/kg sacubitril/valsartan sodium was given for a week. Hematoxylin-eosin(HE) staining, 2, 3, 5-triphenyl-tetrazolium chloride(TTC) staining and echocardiography were used to evaluate the therapeutic effect of sacubitril/valsartan sodium on I/R.The proteomics information of heart tissue was obtained by data-independent acquisition(DIA) proteomics. The analysis results showed that sacubitril/valsartan sodium may mediate the treatment of I/R injury by regulating enzyme activity and immune-related biological processes, up-regulating fatty acid degradation metabolic pathway, PPAR pathway, peroxisome pathway, and down-regulating complement system and ribosome pathway.The results showed that sacubitril/valsartan sodium had a good therapeutic effect on I/R injury.

ORGANISM(S): Mus Musculus

SUBMITTER: Xia Chen  

PROVIDER: PXD045090 | iProX | Mon Sep 04 00:00:00 BST 2023

REPOSITORIES: iProX

Similar Datasets

2022-09-27 | GSE214122 | GEO
2024-03-01 | GSE248442 | GEO
2019-05-09 | GSE129300 | GEO
2016-03-05 | GSE78889 | GEO
2021-09-14 | GSE153494 | GEO
2018-09-19 | GSE120116 | GEO
2018-12-26 | GSE92948 | GEO
2022-11-01 | PXD024581 | Pride
2013-05-29 | E-GEOD-41636 | biostudies-arrayexpress
2020-09-27 | GSE115151 | GEO